Polyrizon Ltd.(PLRZ)

Biotechnology · Ra'anana, TA

$9.67+0.32 (+3.42%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

EBITDA Yield: N/A

Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The EBITDA yield is N/A as of 2026-10-06T20:32:39.762Z.

Stored calculation inputs

Calculation as of: 2026-10-06T20:32:39.762Z.

Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.

TTM operating EBITDA · period ending 2026-06-30: N/A
Quote market capitalization: 10,832,095
Total debt · period ending 2026-06-30: 0
Cash · period ending 2026-06-30: 8,410,000

FMP input reference: 94b5ad3735cc71b9af2236876c301d5f64b1c42b83610b62f031870796dba4d5

EV/EBITDA|Earnings Yield|OCF Yield|FCF Yield|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

PLRZ EBITDA Yield Metrics

EBITDA YIELD

N/A

PLRZ Competitors' EBITDA Yield

PLRZ

Polyrizon Ltd.

Current

Market Cap

$10.83M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BIVI

BioVie Inc.

vs PLRZ

Market Cap

$10.86M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CNSY

Cerenome, Inc.

vs PLRZ

Market Cap

$10.94M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PLUR

Pluri Inc.

vs PLRZ

Market Cap

$10.68M

EBITDA Yield

N/A

TTM Avg

0.09%

3Y Avg

0.09%

5Y Avg

0.09%

GDTC

CytoMed Therapeutics Limited

vs PLRZ

Market Cap

$11.00M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LSTA

Lisata Therapeutics, Inc.

vs PLRZ

Market Cap

$11.02M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

KPRX

Kiora Pharmaceuticals, Inc.

vs PLRZ

Market Cap

$11.08M

EBITDA Yield

N/A

TTM Avg

41.52%

3Y Avg

41.52%

5Y Avg

41.52%

VTGN

VistaGen Therapeutics, Inc.

vs PLRZ

Market Cap

$11.12M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ADIL

Adial Pharmaceuticals, Inc.

vs PLRZ

Market Cap

$10.45M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CABR

Caring Brands, Inc.

vs PLRZ

Market Cap

$11.36M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EBITDA YIELD	TTM	3Y	5Y
Polyrizon Ltd. (PLRZ)	$10.83M	N/A	N/A	N/A	N/A
BioVie Inc. (BIVI)vs ›	$10.86M	N/A	N/A	N/A	N/A
Cerenome, Inc. (CNSY)vs ›	$10.94M	N/A	N/A	N/A	N/A
Pluri Inc. (PLUR)vs ›	$10.68M	N/A	0.09%	0.09%	0.09%
CytoMed Therapeutics Limited (GDTC)vs ›	$11.00M	N/A	N/A	N/A	N/A
Lisata Therapeutics, Inc. (LSTA)vs ›	$11.02M	N/A	N/A	N/A	N/A
Kiora Pharmaceuticals, Inc. (KPRX)vs ›	$11.08M	N/A	41.52%	41.52%	41.52%
VistaGen Therapeutics, Inc. (VTGN)vs ›	$11.12M	N/A	N/A	N/A	N/A
Adial Pharmaceuticals, Inc. (ADIL)vs ›	$10.45M	N/A	N/A	N/A	N/A
Caring Brands, Inc. (CABR)vs ›	$11.36M	N/A	N/A	N/A	N/A

EBITDA Yield Formula & Definition

EBITDA Yield = TTM EBITDA / Enterprise Value

EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EBITDA Yield: N/A

PLRZ EBITDA Yield Metrics

PLRZ Competitors' EBITDA Yield

EBITDA Yield Formula & Definition

Related Metrics